1. Home
  2. TMDX vs LSPD Comparison

TMDX vs LSPD Comparison

Compare TMDX & LSPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • LSPD
  • Stock Information
  • Founded
  • TMDX 1998
  • LSPD 2005
  • Country
  • TMDX United States
  • LSPD Canada
  • Employees
  • TMDX N/A
  • LSPD N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LSPD
  • Sector
  • TMDX Health Care
  • LSPD
  • Exchange
  • TMDX Nasdaq
  • LSPD Nasdaq
  • Market Cap
  • TMDX 2.1B
  • LSPD 2.3B
  • IPO Year
  • TMDX 2019
  • LSPD 2020
  • Fundamental
  • Price
  • TMDX $57.20
  • LSPD $14.61
  • Analyst Decision
  • TMDX Buy
  • LSPD Buy
  • Analyst Count
  • TMDX 11
  • LSPD 14
  • Target Price
  • TMDX $116.10
  • LSPD $18.39
  • AVG Volume (30 Days)
  • TMDX 2.6M
  • LSPD 439.2K
  • Earning Date
  • TMDX 02-24-2025
  • LSPD 02-06-2025
  • Dividend Yield
  • TMDX N/A
  • LSPD N/A
  • EPS Growth
  • TMDX N/A
  • LSPD N/A
  • EPS
  • TMDX 0.94
  • LSPD N/A
  • Revenue
  • TMDX $401,090,000.00
  • LSPD $1,013,184,000.00
  • Revenue This Year
  • TMDX $81.61
  • LSPD $23.29
  • Revenue Next Year
  • TMDX $22.52
  • LSPD $18.47
  • P/E Ratio
  • TMDX $61.04
  • LSPD N/A
  • Revenue Growth
  • TMDX 109.09
  • LSPD 24.73
  • 52 Week Low
  • TMDX $56.03
  • LSPD $11.01
  • 52 Week High
  • TMDX $177.37
  • LSPD $20.09
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 35.74
  • LSPD 37.58
  • Support Level
  • TMDX $58.40
  • LSPD $14.25
  • Resistance Level
  • TMDX $67.80
  • LSPD $15.22
  • Average True Range (ATR)
  • TMDX 4.59
  • LSPD 0.44
  • MACD
  • TMDX -0.27
  • LSPD -0.05
  • Stochastic Oscillator
  • TMDX 4.44
  • LSPD 18.08

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares

Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, New Zealand, United Kingdom, Australia, Germany, and other countries. It derives a majority of its revenue from the United States.

Share on Social Networks: